| Literature DB >> 35966344 |
Ines Tlili1, Rafika Bensghaier1, Latifa Latrous El Atrache1,2, Adel Megriche1.
Abstract
Many antiviral drugs were developed to counteract coronavirus disease, 2019 (COVID-19) with severe acute respiratory syndrome. Therefore, the scientific community's efforts have focused on the detection and quantification of antiviral compounds currently being tested for COVID-19 treatment. Cuttlefish bone powder (CFBP) has been used for the first time as solid-phase extraction (SPE) sorbent for the extraction of SARS CoV-2 antiviral drugs (chloroquine, ritonavir and indomethacin) from water samples. An effective and sensitive method was developed by combining SPE and liquid chromatography- UV detection (LC-UV). An experimental design was applied for the optimization of extraction process. Experimental variables were optimized using Doehlert matrix. The developed method included 50 mg of CFBP sorbent, 20 mL of water sample at pH = 9 and 5 mL of ACN/KH2PO4 buffer solution (80:20, v/v) in the elution step. For validation of the method, selectivity, linearity precision, and sensitivity were evaluated. Extraction recovery percentage of all Sars cov-2 antivirals were above 98.2%. The detection and quantification limits were between 0.1 and 0.5 µg L-1 and 0.6 and 2 µg L-1, respectively. The current study suggested that CFBP has the application potential for the enhanced SPE of SARS CoV-2 antiviral drugs from water samples. © Institute of Chemistry, Slovak Academy of Sciences 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.Entities:
Keywords: Cuttlefish bone powder; Green materials; HPLC–UV and chemometrics; SARS CoV-2 antiviral drugs; Solid-phase extraction
Year: 2022 PMID: 35966344 PMCID: PMC9362547 DOI: 10.1007/s11696-022-02388-6
Source DB: PubMed Journal: Chem Zvesti ISSN: 0366-6352 Impact factor: 2.146
Molecular structure and main physicochemical properties of the studied antivirals
| Drug | Molecular structure | Brut formula | pKa |
|---|---|---|---|
| Chloroquine |
| C18H26ClN3 | 10.1 |
| Indometacin |
| C19H16ClNO4 | 4.50 |
| Ritonavir |
| C37H48N6O5S2 | 2.84 13.68 |
Kinetic and equilibrium models equations (Rigueto et al. 2021)
| Equations | Parameters | |
|---|---|---|
| Q (mg g−1) = ( | Ce (mg L−1) equilibrium concentration, C0 (mg L−1) initial concentration (mg L−1), V(mL) volume and W (mg) mass | |
| % Adsorption = | C0 (mg L−1) initial concentration, Ce (mg L−1) equilibrium concentration | |
| Pseudo-first order | ln (Qe –Qt) = ln Qe – | k1 (min−1) constant rate of pseudo-first order; Qe (mg. g−1) theoretical value of the adsorption capacity |
| Pseudo-second order | k2 (g mg−1 min−1) constant rate of pseudo-second order; Qe (mg g−1) theoretical value of the adsorption capacity | |
| Langmuir | Qm (mg g−1) maximum adsorption capacity; KL (L mg−1) Langmuir constant; Ce (mg L−1) equilibrium concentration | |
| Freundlich | KF (mg g−1) (mg L−1) −1/n;1/n Freundlich constant; Ce (mg L−1) equilibrium concentration | |
Fit of parameter values of the kinetic and isotherm models for biosorption of Chloroquine by CFBP (298 K and pH = 9)
| Models | Parameters | Value |
|---|---|---|
| Pseudo-first order | Qe (mg g−1) | 11.64 |
| k1 (min−1) | 0.016 | |
| R2 | 0.879 | |
| Pseudo-second order | Qe (mg g−1) | 0.369 |
| k2 (g mg−1 min−1) | 0.024 | |
| R2 | 0.998 | |
| Langmuir | Qm (mg g−1) | 50.01 |
| KL | 0.613 | |
| R2 | 0.992 | |
| Freundlich | KF (mg g−1) (mg L−1) −1/n | 4.340 |
| n | 0.770 | |
| R2 | 0.995 |
Fig. 1FTIR spectra of CFBP
Fig. 2SEM of CFBP
Fig. 3Elemental analysis of CFBP (EDX)
Fig. 4XRD pattern of CFBP
Fig. 5(a) The effect of contact time, (b) pH and (c) the temperature on the adsorption rate of chloroquine on CFBP
Fig. 6(a) Pseudo-first order, (b) pseudo-second order, (c) Freundlich model and (d) Langmuir model
Fig. 7Influence of the solvent type on the extraction recovery of studied antivirals
Fig. 8Schematic of experimental design
Investigated variables and their levels studied in the 23 factorial design
| Coded variables (Xi) | Factors (Ui) | Experimental field | Coded variables (Xi) |
|---|---|---|---|
| value min. (−1) | value max. (+ 1) | ||
| X1 | U1: sample volume (mL) | 10 | 30 |
| X2 | U2: % elution of ACN (%) | 20 | 80 |
| X3 | U3: pH of sample | 3 | 11 |
Doehlert matrix experiments
| N° exp | Rand | pH | VACN | Volume sample |
|---|---|---|---|---|
| mL | mL | |||
| 1 | 4 | 11 | 2.50 | 20.00 |
| 2 | 10 | 3 | 2.50 | 20.00 |
| 3 | 6 | 9 | 3.80 | 20.00 |
| 4 | 14 | 5 | 1.20 | 20.00 |
| 5 | 11 | 9 | 1.20 | 20.00 |
| 6 | 15 | 5 | 3.80 | 20.00 |
| 7 | 13 | 9 | 2.93 | 28.16 |
| 8 | 1 | 5 | 2.07 | 11.84 |
| 9 | 2 | 9 | 2.07 | 11.84 |
| 10 | 8 | 7 | 3.37 | 11.84 |
| 11 | 3 | 5 | 2.93 | 28.16 |
| 12 | 12 | 7 | 1.63 | 28.16 |
| 13 | 7 | 7 | 2.50 | 20.00 |
| 14 | 9 | 7 | 2.50 | 20.00 |
| 15 | 5 | 7 | 2.50 | 20.00 |
Fig. 9(a) Contour plots of extraction recovery versus pH and percent ACN elution (%); (b) corresponding three-dimensional plot; (c) contour plots of extraction recovery versus pH and sample volume(mL); (d) corresponding three-dimensional plot; (e) contour plots of extraction recovery versus percent ACN elution (%) and sample volume (mL); (f) corresponding three-dimensional plot
Fig. 10Chromatogram obtained from the analysis of three AVS in water sample by the optimized CFBP-SPE-HPLC/UV method
Correlation coefficients, coefficients of variation, Recovery percentage, LOD and LOQ obtained from the application of SPE–CFBP-HPLC/UV method with three repetitions, in water samples fortified with AVS (10 mg L−1)
| Linearity | Precision | Recovery | Sensitivity | ||
|---|---|---|---|---|---|
| AVS | R2 | CV | R % | LOD (µg L−1) | LOQ (µg L−1) |
| Chloroquine | 0.999 | 0.60 | 95.6 | 0.2 | 0.8 |
| Ritonavir | 0.998 | 0.93 | 92.7 | 0.5 | 2 |
| Indometacin | 0.999 | 0.41 | 98.2 | 0.1 | 0.6 |
Reported solid-phase extraction methods for determination of micropollutants in water samples
| Sorbent | Analytical method | Micropollutants | Recovery (%) | LOD | Refs. |
|---|---|---|---|---|---|
| Pine bark | HPLC–UV | Phenylbutazone, sulfamethazine, carbendazim, and linuron | – | 0.11—0.4 µg L−1 | Khazri et al. ( |
| HPLC–UV | Ttriazole fungicides | 70–112 | 30–50 µg L−1 | (Kachangoon et al. ( | |
| Chitosan/lawsone composite | HPLC–UV | Dimethyl phthalate, di-butyl phthalate and benzyl butyl phthalate | 67–106 | 0.03–0.15 ng g−1 | Samadi and Es’haghi ( |
| Fe3O4-MWCNTs | HPLC–MS/MS | Naproxen, Ketoprofen, Piroxicam, Diflunisal, Celecoxib | 78–93 | 0.05–3.6 ng mL−1 | Hsen and Latrous ( |
| CFBP | HPLC–UV | Chloroquine, ritonavir, and indometacin | 98.2 | 0.1–0.5 µg L−1 | The present work |
Fig. 11AVS removal efficiencies in six successive recycle runs